Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
3.005
+0.015 (0.50%)
At close: Nov 3, 2026, 4:00 PM EST
2.850
-0.155 (-5.16%)
After-hours: Nov 3, 2026, 4:51 PM EST
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $5.75 million as of November 3, 2026. Its market cap has decreased by 35.76% in one year.
Market Cap
5.75M
Enterprise Value
4.91M
1-Year Change
-35.76%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $5.75M, a decrease of -98.23%. That is a compound annual growth rate of -18.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 6.08M | -25.57% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 6.61M |
| FibroBiologics | 6.47M |
| Enveric Biosciences | 6.40M |
| Processa Pharmaceuticals | 6.33M |
| Aprea Therapeutics | 6.10M |
| XTL Biopharmaceuticals | 5.90M |
| Evogene | 5.84M |
| Alzamend Neuro | 5.84M |